First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial.

Saved in:
Bibliographic Details
Title: First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial.
Authors: Colao A; Department of Molecular and Clinical Endocrinology and Oncology, Federico II, University of Naples, Italy. colao@unina.it, Pivonello R, Rosato F, Tita P, De Menis E, Barreca A, Ferrara R, Mainini F, Arosio M, Lombardi G
Source: Clinical endocrinology [Clin Endocrinol (Oxf)] 2006 Mar; Vol. 64 (3), pp. 342-51.
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Blackwell Publishing Country of Publication: England NLM ID: 0346653 Publication Model: Print Cited Medium: Print ISSN: 0300-0664 (Print) Linking ISSN: 03000664 NLM ISO Abbreviation: Clin Endocrinol (Oxf) Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0300-0664
DOI:10.1111/j.1365-2265.2006.02467.x